Skip to content

Miadazolam plasma-concentration after anesthesia-premedication in clinical routine

Miadazolam plasma-concentration after anesthesia-premedication in clinical routine

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00005429
Enrollment
50
Registered
2014-01-03
Start date
2013-12-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients who must undergo an operation in general anesthesia with midazolam premedication

Interventions

Group 1: Determination of Midazolam-plasma level

Sponsors

Institut für Anästhesie und IntensivmedizinKantonsspital Frauenfeld
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: planned operation in general anesthesia, midazolam premedication indicated according to internal standard

Exclusion criteria

Exclusion criteria: Allergy to benzodiazepines, respiratory insufficiency, myasthenia, OSAS, psychiatric disorder, hepatic and/or renal insufficiency, pregnancy or breast feeding, sedating and/or enzym-relevant medication, BMI > 40, severe gastro-intestinal illness, need for benzodiazepines intraoperative

Design outcomes

Primary

MeasureTime frame
Midazolam plasma Levels before induction of anesthesia

Secondary

MeasureTime frame
Midazolam plasma levels at end of anesthesia, sedation scores (RAAS 0-20) and BIS score when arriving in OR, patient satisfaction (VAS 0-10) the next day.

Countries

Switzerland

Contacts

Public ContactAlexander Dullenkopf

Institut für Anästhesie und IntensivmedizinKantonsspital Frauenfeld

alexander.dullenkopf@stgag.ch0041527237560

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 12, 2026